BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago La Banque Cler trace sa feuille de route avec la stratégie 2026+ Banque Cler Gestion De Fortune Stratégie 2026+ Néobanking Zak Clarté Financière
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago Banque Cler draws up its roadmap with the 2026+ strategy Wealth Management Cler Bank Néobanking Zak Strategy 2026+ Financial Clarity
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago Sandoz Expands Rivaroxaban Access in Germany Patent Germany Sandoz Rivaroxaban Antithrombotic
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago Sandoz élargit l'accès au rivaroxaban en Allemagne Allemagne Brevet Sandoz Rivaroxaban Antithrombotique
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago SoftwareOne Sees Decline in Revenue, Improved Margins in H1 2025 EBITDA Margin Revenue Decline SoftwareOne Cost Synergies Crayon Integration
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago SoftwareOne constate une baisse de son chiffre d'affaires et une amélioration de ses marges au premier semestre 2025 Marge D'EBITDA Baisse Des Revenus LogicielOne Synergies De Coûts Intégration De Crayon
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago STRABAG SE Reports Strong Growth in Key Financial Metrics for H1 2025 Construction Industry Order Backlog STRABAG SE Financial Growth H1 2025 Results
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago STRABAG SE annonce une forte croissance de ses principaux indicateurs financiers au premier semestre 2025 Croissance Financière STRABAG SE Carnet De Commandes Industrie De La Construction Résultats Du Premier Semestre 2025
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago Biophytis lance son essai clinique de phase 3 sur la sarcopénie Biophytis Belgique Essai Clinique Sarcopénie EMA
BRIEF published on 08/28/2025 at 07:05, 11 months 17 days ago Biophytis Gains Regulatory Approval for Phase 3 Sarcopenia Trial Biophytis Regulatory Approval Clinical Trial Sarcopenia Phase 3
Published on 08/15/2026 at 00:50, 4 hours 26 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 5 hours 1 minute ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 5 hours 31 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 5 hours 51 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 6 hours 16 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 11 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 13 hours 11 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 13 hours 47 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 11 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 11 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 11 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 11 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
